6Colao A,Viatale G,Cappabianca P,et al.Outcome of cabergoline treatment in men with prolactinoma:effects of a 24-month treatment on prolactin levels,tumor mass,recovery of pituitary function and semen analysis.J Clin Endocrinol Metab,2004,89:1704-1711.
1Aziz KMA,Van Loveren HR,Tew JM,et a1.The Kawase approach to retrosellar and upper clival basilar aneurysms.Neurosurgery.1999,44:1225-1236.
2Kohal PJ,Goufman DB,Parnes SM,et al.Transsphenoidal hypophysectomy through the external rhinoplasty approach.Otolaryngol Head Neck Surg,1994,111:197-200.
3Gamea A, Fathi M, El-Guindy A. The use of the rigid endoscope in trans-sphenoidal pituitary surgery. J Laryngol Otol, 1994,108:19 - 22.
5Molitch ME, Thorner O, Wilson C. Mangement of prolactionmas. J Clin Endocrinol Metab, 1997,82:996-1006.
6Molitch ME. Medical treatment of prolactinomas. Endocrinol Metab Clin North Am, 1999, 28:143-169.
7Grebe SK, Delahunt JW, Feek CM. Treatment of extensively invasive (giant) prolactinomas with bromocriptine. N Z Med J,1992,105:129-131.
8Sieck JO, Niles NL, Jinkins JR, et al. Extrasellar prolactinomas:successful management of 24 patients using bromocriptine. Horm Res, 1986,23:167-176.
9Van′t Verlaat JW, Croughs RJ, Hendriks MJ, et al. Results of primary treatment with bromccriptine of prolactinomas with extrasellar extension. Can J Neurol Sci, 1990,17 ;71-73.
10Molitch ME, Elton RL, Blackwell RE, et al. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab, 1985,60:698-705.
